These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35693548)

  • 21. [Late diagnosis of rhinocerebral mucormycosis in patients with COVID-19 (case studies)].
    Kurysheva NI; Kapkova SG; Naumova VI; Smolev DM; Lishchuk SV; Nekrasova EY; Kim VE
    Vestn Oftalmol; 2023; 139(6):110-121. PubMed ID: 38235637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in mucormycosis hospitalizations in southeastern Brazil during the COVID-19 pandemic: a 2010-2021 time series.
    Santos ILD; Sartori CS; Bueno AG; Mendes ET
    Rev Soc Bras Med Trop; 2023; 56():e0333. PubMed ID: 36820656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucormycosis in COVID-19 pandemic and its neurovascular spread.
    Pal P; Singh B; Singla S; Kaur R
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2965-2972. PubMed ID: 34637017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spotlight on the Mucormycosis Outbreak: A Deadly Fungal Infection That Followed the COVID-19 Pandemic.
    Patel SN; Shah S; Panchal J; Desai C; Upadhya IB; Patel M
    Cureus; 2023 Feb; 15(2):e35095. PubMed ID: 36938207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms.
    Pourazizi M; Hakamifard A; Peyman A; Mohammadi R; Dehghani S; Tavousi N; Hosseini NS; Azhdari Tehrani H; Abtahi-Naeini B
    Parasite Immunol; 2024 Jan; 46(1):e13016. PubMed ID: 37846902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Profile of Mucormycosis Patients during Coronavirus Disease 2019 Pandemic: A Retrospective Observational Study.
    Gondane B; Jain SK; Dube S
    J Assoc Physicians India; 2024 Mar; 72(3):27-31. PubMed ID: 38736113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological association of mucormycosis in COVID 19 pandemic.
    Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
    Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucocutaneous manifestations of COVID-19-associated mucormycosis: A retrospective cross-sectional study.
    Sachan S; Suvirya S; Yadav K; Gupta P; Saraswat A; Verma P; Chandra U; Singh BP; Chaudhary SC; Dwivedi DK; Garg RK; Singhai A; Malhotra KP; Parihar A; Kumar S
    Indian J Dermatol Venereol Leprol; 2023; 89(4):510-523. PubMed ID: 36688884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.
    Upadhayay P; Bansal K; Goyal A
    Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post COVID-19 rhinocerebral mucormycosis: a case report and literature review.
    El Korbi A; Bhar S; Bergaoui E; Harrathi K; Koubaa J
    Pan Afr Med J; 2022; 42():202. PubMed ID: 36284570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19-associated mucormycosis: An updated systematic review of literature.
    Pal R; Singh B; Bhadada SK; Banerjee M; Bhogal RS; Hage N; Kumar A
    Mycoses; 2021 Dec; 64(12):1452-1459. PubMed ID: 34133798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucormycosis in pre-COVID-19 and COVID-19 era: A study of prevalence, risk factors and clinical features.
    Arjmand P; Bahrami M; Mohammadie ZE; Taherynejad M; Khorasani NY; Mehrad-Majd H; Roshanzamir I; Bakhshaee M
    Laryngoscope Investig Otolaryngol; 2022 Sep; 7(5):1343-50. PubMed ID: 36249085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surge of mucormycosis during the COVID-19 pandemic.
    Dam P; Cardoso MH; Mandal S; Franco OL; Sağıroğlu P; Polat OA; Kokoglu K; Mondal R; Mandal AK; Ocsoy I
    Travel Med Infect Dis; 2023; 52():102557. PubMed ID: 36805033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.